510(k) K113751

RANDOX COCAINE METABOLITE by Randox Laboratories, Ltd. — Product Code DIO

K113751 is an FDA 510(k) premarket notification submitted by Randox Laboratories, Ltd. for the device "RANDOX COCAINE METABOLITE". The FDA issued a decision of Substantially Equivalent on May 8, 2012. The device falls under product code DIO (Enzyme Immunoassay, Cocaine And Cocaine Metabolites), a Class II device regulated under 21 CFR 862.3250. Randox Laboratories, Ltd. has 115 other 510(k) clearances on record.

Clearance details

Decision
SESE (Substantially Equivalent)
Decision Date
May 8, 2012
Date Received
Dec 21, 2011
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device classification

Device Name
Enzyme Immunoassay, Cocaine And Cocaine Metabolites
Device Class
Class II
Regulation Number
862.3250
Review Panel
TX
Submission Type
510(k)

Need the full FDA record for Randox Laboratories, Ltd.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: FDA 510(k) database entry for K113751. Report a data issue: hello@regdatalab.com.